The Selective Oestrogen Receptor Modulator, LY362321, is Not Neuroprotective in a Rat Model of Transient Focal Ischaemia
Tracy D. Farr(University of Nottingham), I. Mhairi Macrae(Aurum Biosciences (United Kingdom)), H Carswell(University of Strathclyde), Denis McCann(Eli Lilly (United States)), Masahiko Sato(Tokyo University of Science), H.U. Bryant, Jeffrey A. Dodge(Eli Lilly (United States))
Cited by 6
Related Papers
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
|Journal of Clinical Investigation|1991|1k
The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments)
|Journal of Cerebral Blood Flow & Metabolism|2017|203
Novel targets, treatments, and advanced models for intracerebral haemorrhage
|EBioMedicine|2022|165
Quantitative and Qualitative Impairments in Skilled Reaching in the Mouse ( <i>Mus musculus</i> ) After a Focal Motor Cortex Stroke
|Stroke|2002|160
Visualizing Cell Death in Experimental Focal Cerebral Ischemia: Promises, Problems, and Perspectives
|Journal of Cerebral Blood Flow & Metabolism|2011|151